 | • レポートコード：QYR2104Z1075 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、がん治療・生物学的製剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、ホルモン療法、生物療法）、用途別市場規模（消費（販売）、家庭、病院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん治療・生物学的製剤の市場動向 ・企業の競争状況、市場シェア ・がん治療・生物学的製剤の種類別市場規模（化学療法、放射線療法、ホルモン療法、生物療法） ・がん治療・生物学的製剤の用途別市場規模（消費（販売）、家庭、病院） ・がん治療・生物学的製剤の北米市場規模2016-2027（アメリカ、カナダ） ・がん治療・生物学的製剤のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん治療・生物学的製剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん治療・生物学的製剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん治療・生物学的製剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol-Myers Squibb、AstraZeneca、Pfizer、Biogen IDEC、Sanofi、Genentech、Novartis、Johnson & Johnson、Roche and Schering-Plough） ・結論 |
The global cancer therapeutics and biotherapeutics market is drived by the introduction of products such as gemcitabin, oxaliplatin and pemetrexed.
The increasing occurrence of different types of cancer and the increasing proliferation of new players in this market are expected to boost the development of global cancer therapeutics and biotherapeutics market.
Market Analysis and Insights: Global Cancer Therapeutics And Biotherapeutics Market
The global Cancer Therapeutics And Biotherapeutics market size is projected to reach US$ 11780 million by 2026, from US$ 8707.3 million in 2019, at a CAGR of 4.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Therapeutics And Biotherapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Therapeutics And Biotherapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Therapeutics And Biotherapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Therapeutics And Biotherapeutics market.
Global Cancer Therapeutics And Biotherapeutics Scope and Market Size
Cancer Therapeutics And Biotherapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Therapeutics And Biotherapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Radiation Therapy
Hormone Therapy
Biotherapy
Segment by Application
Consumption (Sales)
Household
Hospital
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bristol-Myers Squibb
AstraZeneca
Pfizer
Biogen IDEC
Sanofi
Genentech
Novartis
Johnson & Johnson
Roche and Schering-Plough
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Therapeutics And Biotherapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Hormone Therapy
1.2.5 Biotherapy
1.3 Market by Application
1.3.1 Global Cancer Therapeutics And Biotherapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Consumption (Sales)
1.3.3 Household
1.3.4 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Therapeutics And Biotherapeutics Market Perspective (2016-2027)
2.2 Cancer Therapeutics And Biotherapeutics Growth Trends by Regions
2.2.1 Cancer Therapeutics And Biotherapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Therapeutics And Biotherapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Therapeutics And Biotherapeutics Industry Dynamic
2.3.1 Cancer Therapeutics And Biotherapeutics Market Trends
2.3.2 Cancer Therapeutics And Biotherapeutics Market Drivers
2.3.3 Cancer Therapeutics And Biotherapeutics Market Challenges
2.3.4 Cancer Therapeutics And Biotherapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Therapeutics And Biotherapeutics Players by Revenue
3.1.1 Global Top Cancer Therapeutics And Biotherapeutics Players by Revenue (2016-2021)
3.1.2 Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Therapeutics And Biotherapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Therapeutics And Biotherapeutics Revenue
3.4 Global Cancer Therapeutics And Biotherapeutics Market Concentration Ratio
3.4.1 Global Cancer Therapeutics And Biotherapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Therapeutics And Biotherapeutics Revenue in 2020
3.5 Cancer Therapeutics And Biotherapeutics Key Players Head office and Area Served
3.6 Key Players Cancer Therapeutics And Biotherapeutics Product Solution and Service
3.7 Date of Enter into Cancer Therapeutics And Biotherapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Therapeutics And Biotherapeutics Breakdown Data by Type
4.1 Global Cancer Therapeutics And Biotherapeutics Historic Market Size by Type (2016-2021)
4.2 Global Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Type (2022-2027)
5 Cancer Therapeutics And Biotherapeutics Breakdown Data by Application
5.1 Global Cancer Therapeutics And Biotherapeutics Historic Market Size by Application (2016-2021)
5.2 Global Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Therapeutics And Biotherapeutics Market Size (2016-2027)
6.2 North America Cancer Therapeutics And Biotherapeutics Market Size by Type
6.2.1 North America Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2021)
6.2.2 North America Cancer Therapeutics And Biotherapeutics Market Size by Type (2022-2027)
6.2.3 North America Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2027)
6.3 North America Cancer Therapeutics And Biotherapeutics Market Size by Application
6.3.1 North America Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2021)
6.3.2 North America Cancer Therapeutics And Biotherapeutics Market Size by Application (2022-2027)
6.3.3 North America Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2027)
6.4 North America Cancer Therapeutics And Biotherapeutics Market Size by Country
6.4.1 North America Cancer Therapeutics And Biotherapeutics Market Size by Country (2016-2021)
6.4.2 North America Cancer Therapeutics And Biotherapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cancer Therapeutics And Biotherapeutics Market Size (2016-2027)
7.2 Europe Cancer Therapeutics And Biotherapeutics Market Size by Type
7.2.1 Europe Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2021)
7.2.2 Europe Cancer Therapeutics And Biotherapeutics Market Size by Type (2022-2027)
7.2.3 Europe Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2027)
7.3 Europe Cancer Therapeutics And Biotherapeutics Market Size by Application
7.3.1 Europe Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2021)
7.3.2 Europe Cancer Therapeutics And Biotherapeutics Market Size by Application (2022-2027)
7.3.3 Europe Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2027)
7.4 Europe Cancer Therapeutics And Biotherapeutics Market Size by Country
7.4.1 Europe Cancer Therapeutics And Biotherapeutics Market Size by Country (2016-2021)
7.4.2 Europe Cancer Therapeutics And Biotherapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size (2016-2027)
8.2 Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Type
8.2.1 Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Application
8.3.1 Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Region
8.4.1 Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Therapeutics And Biotherapeutics Market Size (2016-2027)
9.2 Latin America Cancer Therapeutics And Biotherapeutics Market Size by Type
9.2.1 Latin America Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Therapeutics And Biotherapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2027)
9.3 Latin America Cancer Therapeutics And Biotherapeutics Market Size by Application
9.3.1 Latin America Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Therapeutics And Biotherapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2027)
9.4 Latin America Cancer Therapeutics And Biotherapeutics Market Size by Country
9.4.1 Latin America Cancer Therapeutics And Biotherapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Therapeutics And Biotherapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size (2016-2027)
10.2 Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Type
10.2.1 Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Application
10.3.1 Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Country
10.4.1 Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Introduction
11.1.4 Bristol-Myers Squibb Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Cancer Therapeutics And Biotherapeutics Introduction
11.2.4 AstraZeneca Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Cancer Therapeutics And Biotherapeutics Introduction
11.3.4 Pfizer Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Biogen IDEC
11.4.1 Biogen IDEC Company Details
11.4.2 Biogen IDEC Business Overview
11.4.3 Biogen IDEC Cancer Therapeutics And Biotherapeutics Introduction
11.4.4 Biogen IDEC Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
11.4.5 Biogen IDEC Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Cancer Therapeutics And Biotherapeutics Introduction
11.5.4 Sanofi Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Genentech
11.6.1 Genentech Company Details
11.6.2 Genentech Business Overview
11.6.3 Genentech Cancer Therapeutics And Biotherapeutics Introduction
11.6.4 Genentech Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
11.6.5 Genentech Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Cancer Therapeutics And Biotherapeutics Introduction
11.7.4 Novartis Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Cancer Therapeutics And Biotherapeutics Introduction
11.8.4 Johnson & Johnson Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
11.8.5 Johnson & Johnson Recent Development
11.9 Roche and Schering-Plough
11.9.1 Roche and Schering-Plough Company Details
11.9.2 Roche and Schering-Plough Business Overview
11.9.3 Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Introduction
11.9.4 Roche and Schering-Plough Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
11.9.5 Roche and Schering-Plough Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Therapeutics And Biotherapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Hormone Therapy
Table 5. Key Players of Biotherapy
Table 6. Global Cancer Therapeutics And Biotherapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cancer Therapeutics And Biotherapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cancer Therapeutics And Biotherapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cancer Therapeutics And Biotherapeutics Market Share by Regions (2016-2021)
Table 10. Global Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cancer Therapeutics And Biotherapeutics Market Share by Regions (2022-2027)
Table 12. Cancer Therapeutics And Biotherapeutics Market Trends
Table 13. Cancer Therapeutics And Biotherapeutics Market Drivers
Table 14. Cancer Therapeutics And Biotherapeutics Market Challenges
Table 15. Cancer Therapeutics And Biotherapeutics Market Restraints
Table 16. Global Cancer Therapeutics And Biotherapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cancer Therapeutics And Biotherapeutics Market Share by Players (2016-2021)
Table 18. Global Top Cancer Therapeutics And Biotherapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Therapeutics And Biotherapeutics as of 2020)
Table 19. Ranking of Global Top Cancer Therapeutics And Biotherapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cancer Therapeutics And Biotherapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Therapeutics And Biotherapeutics Product Solution and Service
Table 23. Date of Enter into Cancer Therapeutics And Biotherapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cancer Therapeutics And Biotherapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Cancer Therapeutics And Biotherapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cancer Therapeutics And Biotherapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cancer Therapeutics And Biotherapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cancer Therapeutics And Biotherapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cancer Therapeutics And Biotherapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cancer Therapeutics And Biotherapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cancer Therapeutics And Biotherapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cancer Therapeutics And Biotherapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cancer Therapeutics And Biotherapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cancer Therapeutics And Biotherapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cancer Therapeutics And Biotherapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cancer Therapeutics And Biotherapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cancer Therapeutics And Biotherapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bristol-Myers Squibb Company Details
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Product
Table 66. Bristol-Myers Squibb Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021) & (US$ Million)
Table 67. Bristol-Myers Squibb Recent Development
Table 68. AstraZeneca Company Details
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Cancer Therapeutics And Biotherapeutics Product
Table 71. AstraZeneca Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021) & (US$ Million)
Table 72. AstraZeneca Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Cancer Therapeutics And Biotherapeutics Product
Table 76. Pfizer Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Biogen IDEC Company Details
Table 79. Biogen IDEC Business Overview
Table 80. Biogen IDEC Cancer Therapeutics And Biotherapeutics Product
Table 81. Biogen IDEC Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021) & (US$ Million)
Table 82. Biogen IDEC Recent Development
Table 83. Sanofi Company Details
Table 84. Sanofi Business Overview
Table 85. Sanofi Cancer Therapeutics And Biotherapeutics Product
Table 86. Sanofi Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021) & (US$ Million)
Table 87. Sanofi Recent Development
Table 88. Genentech Company Details
Table 89. Genentech Business Overview
Table 90. Genentech Cancer Therapeutics And Biotherapeutics Product
Table 91. Genentech Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021) & (US$ Million)
Table 92. Genentech Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Cancer Therapeutics And Biotherapeutics Product
Table 96. Novartis Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. Johnson & Johnson Company Details
Table 99. Johnson & Johnson Business Overview
Table 100. Johnson & Johnson Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021) & (US$ Million)
Table 101. Johnson & Johnson Recent Development
Table 102. Roche and Schering-Plough Company Details
Table 103. Roche and Schering-Plough Business Overview
Table 104. Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Product
Table 105. Roche and Schering-Plough Revenue in Cancer Therapeutics And Biotherapeutics Business (2016-2021) & (US$ Million)
Table 106. Roche and Schering-Plough Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Therapeutics And Biotherapeutics Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Hormone Therapy Features
Figure 5. Biotherapy Features
Figure 6. Global Cancer Therapeutics And Biotherapeutics Market Share by Application: 2020 VS 2027
Figure 7. Consumption (Sales) Case Studies
Figure 8. Household Case Studies
Figure 9. Hospital Case Studies
Figure 10. Cancer Therapeutics And Biotherapeutics Report Years Considered
Figure 11. Global Cancer Therapeutics And Biotherapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cancer Therapeutics And Biotherapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cancer Therapeutics And Biotherapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Cancer Therapeutics And Biotherapeutics Market Share by Regions (2022-2027)
Figure 15. Global Cancer Therapeutics And Biotherapeutics Market Share by Players in 2020
Figure 16. Global Top Cancer Therapeutics And Biotherapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Therapeutics And Biotherapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cancer Therapeutics And Biotherapeutics Revenue in 2020
Figure 18. Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Cancer Therapeutics And Biotherapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cancer Therapeutics And Biotherapeutics Market Share by Type (2016-2027)
Figure 22. North America Cancer Therapeutics And Biotherapeutics Market Share by Application (2016-2027)
Figure 23. North America Cancer Therapeutics And Biotherapeutics Market Share by Country (2016-2027)
Figure 24. United States Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cancer Therapeutics And Biotherapeutics Market Share by Type (2016-2027)
Figure 28. Europe Cancer Therapeutics And Biotherapeutics Market Share by Application (2016-2027)
Figure 29. Europe Cancer Therapeutics And Biotherapeutics Market Share by Country (2016-2027)
Figure 30. Germany Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cancer Therapeutics And Biotherapeutics Market Share by Region (2016-2027)
Figure 40. China Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cancer Therapeutics And Biotherapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Cancer Therapeutics And Biotherapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Cancer Therapeutics And Biotherapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cancer Therapeutics And Biotherapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cancer Therapeutics And Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
Figure 62. Biogen IDEC Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
Figure 64. Genentech Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
Figure 66. Johnson & Johnson Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
Figure 67. Roche and Schering-Plough Revenue Growth Rate in Cancer Therapeutics And Biotherapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed